Grivas and Wright Weigh In on the Benefits of Multidisciplinary Care in Bladder Cancer

Welcome to OncLive On Air^TM! I’m your host today, Jessica Hergert.

OncLive On Air^TM is a podcast from OncLive, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

In today’s episode, we had the pleasure of speaking with Petros Grivas, MD, PhD, a physician of the Seattle Cancer Care Alliance, associate professor in the Division of Medical Oncology and clinical director of the Genitourinary Cancers Program at the University of Washington School of Medicine, and associate professor in the Clinical Research Division at the Fred Hutchinson Cancer Research Center, and Jonathan L. Wright, MD, MS, FACS, a physician of the Seattle Cancer Care Alliance, the Paul H. Lange, MD Endowed Professorship in Urological Oncology, an associate professor in the Department of Urology at the University of Washington School of Medicine, medical director of the University of Washington Medical Center Urology Clinic, and an associate professor in the Public Health Sciences Division at the Fred Hutchinson Cancer Research Center, to discuss the importance of multidisciplinary care in the treatment of patients with bladder cancer.

In our exclusive interview, Drs Grivas and Wright discussed the goals of the Seattle Cancer Care Alliance Bladder Cancer Multidisciplinary Clinic, data that support the use of a multidisciplinary approach in bladder cancer, and the lingering effects of the COVID-19 pandemic on collaboration across health care specialties.